Abstract: A configuration information setting method including: receiving a user-triggered information setting indication; generating, according to the information setting indication, an information setting instruction including setting indication data, the setting indication data configured to instruct the source driver to set configuration information of the source driver according to the setting indication data; and transmitting the information setting instruction to the source driver via the first signal line.

Abstract: This application discloses a data transmission method, a data transmission circuit, a display device and a storage medium, and relates to the field of display manufacturing. The method is used for a timing controller, the method including sending a link stability check data to a source driver after clock calibration, receiving feedback information sent by the source driver, where the feedback information is generated by the source driver when judging that the received link stability check data is correct, and sending target data to the source driver based on the feedback information.

Abstract: Provided herein are compounds of formula (I)-(VI): wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Abstract: A drive control method, an assembly and a display device, belonging to the field of panel manufacturing, for signal drive control of a display panel. The drive control method is applied to a time sequence controller, the time sequence controller is connected through a first signal line to a plurality of source drivers which are connected in parallel. The drive control method includes generating a broadcast configuration instruction, the broadcast configuration instruction being used for instructing a plurality of source drivers to perform driver configuration according to the broadcast configuration instruction, and sending the broadcast configuration instruction through the first signal line.

Abstract: A signal transmission method and related timing controller, source driver and display device are disclosed. The method includes scrambling a signal to be transmitted by a transmitting unit to obtain a scrambled signal. Each frame of the scrambled signal includes at least one first identification signal sequentially arranged in time domain, and a number of the first identification signals in the scrambled signal is equal to a number of the first identification signals in the scrambled signals of other transmitting units in the plurality of transmitting units. The method includes transmitting the scrambled signal to a corresponding receiving unit, where the first identification signal is configured to indicate linear feedback shift registers of the transmitting unit and the corresponding receiving unit to perform a reset operation, and after each collective reset operation is completed, the corresponding receiving unit outputs a display signal to the display panel.

Abstract: The present disclosure discloses an image enhancement method and device. The method comprises: performing logarithm related processing on a grayscale value matrix Y of an original image to obtain a logarithmic matrix L_LOG; quantizing the logarithmic matrix L_LOG to obtain a quantized matrix Y_RE; and obtaining an enhanced image of the original image according to the quantized matrix Y_RE, wherein quantizing the logarithmic matrix L_LOG comprises: when the logarithmic matrix L_LOG is quantized to be within a grayscale range of a certain depth, causing a zero point of the logarithmic matrix L_LOG to be close to an average value of the grayscale value matrix Y.

Abstract: Provided herein are optically active compounds of the formulae (ii); and (III) and pharmaceutical compositions thereof. Also provided herein are processes of making these compounds and resolving the racemic mixture or the enrichment of same with in one of its enantiomers to provide (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N?-bis(ethylene)phosphoramidate, and methods of treating cancer comprising administering such compounds.

Abstract: Provided herein are compounds of formula I: wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Abstract: Provided herein are compounds of formula I: wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Abstract: The present disclosure discloses an image enhancement method and device. The method comprises: performing logarithm related processing on a grayscale value matrix Y of an original image to obtain a logarithmic matrix L_LOG; quantizing the logarithmic matrix L_LOG to obtain a quantized matrix Y_RE; and obtaining an enhanced image of the original image according to the quantized matrix Y_RE, wherein quantizing the logarithmic matrix L_LOG comprises: when the logarithmic matrix L_LOG is quantized to be within a grayscale range of a certain depth, causing a zero point of the logarithmic matrix L_LOG to be close to an average value of the grayscale value matrix Y.

Abstract: A refresh rate adjustment method and circuit, a display device, and a storage medium, which pertains to the field of display technologies. The method includes acquiring a current driving refresh rate of a driving apparatus; determining whether the driving refresh rate is less than a driving refresh rate threshold; in response to the driving refresh rate being less than the driving refresh rate threshold, adjusting a display refresh rate of a display device, so that an adjusted display refresh rate is P times the driving refresh rate, and the adjusted display refresh rate is greater than the driving refresh rate threshold, where P is an integer greater than one.

Abstract: A speaker, a television provided with the speaker and a multimedia device are provided. The speaker includes a box body and a plurality of transducer units installed within the box body by means of parallel connection: front sound cavities of the plurality of transducer units are independent of each other, respectively; and the plurality of transducer units share one back sound cavity. The speaker possesses such advantages that it has a high sound pressure level output and a smaller power consumption, it is usable to reduce the back-cavity acoustic resistance, and it is usable to raise the lower frequency limit in the low frequency range.

Abstract: The present invention provides a new method for making TH-302 and solid forms thereof. The compound in its solid form is an effective anti-cancer agent and may be used in various pharmaceutical compositions, and are particularly effective for the treatment of cancer. The invention also provides a method for preparing such compounds and forms and for treating cancer in a mammal comprising the step of administering a therapeutically effective amount of a solid form of TH-302 thereof.

Abstract: A technique is described herein for reducing blur caused by an imaging assembly of a depth camera system. In a runtime phase, the technique involves receiving a sensor image that is generated in response to return radiation reflected from a scene. The return radiation passes through an optical element (such as a visor element) of the imaging assembly, which produces blur due to the scattering of radiation. The technique then deconvolves the sensor image with a kernel, to provide a blur-reduced image. The kernel represents a point spread function that describes the distortion-related characteristics of at least the optical element. The technique then uses the blur-reduced image to calculate a depth image. The technique also encompasses a calibration-phase process for generating the kernel by modeling blur that occurs near an edge of a test object within a test image.

Abstract: The present invention provides a new method for making TH-302 and solid forms thereof. The compound in its solid form is an effective anti-cancer agent and may be used in various pharmaceutical compositions, and are particularly effective for the treatment of cancer. The invention also provides a method for preparing such compounds and forms and for treating cancer in a mammal comprising the step of administering a therapeutically effective amount of a solid form of TH-302 thereof.

Abstract: Provided herein are optically active compounds of the formulae (ii); and (III) and pharmaceutical compositions thereof. Also provided herein are processes of making these compounds and resolving the racemic mixture or the enrichment of same with in one of its enantiomers to provide (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N?-bis(ethylene)phosphoramidate, and methods of treating cancer comprising administering such compounds.

Abstract: Provided herein are compounds of formula (I)-(VI), wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Abstract: Provided herein are compounds of formula I, wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Abstract: Provided herein are compounds of formula I: wherein the variables are defined herein, processes of making them, and methods of treating cancer comprising administering such compounds.

Abstract: The present invention provides a new method for making TH-302 and solid forms thereof. The compound in its solid form is an effective anti-cancer agent and may be used in various pharmaceutical compositions, and are particularly effective for the treatment of cancer. The invention also provides a method for preparing such compounds and forms and for treating cancer in a mammal comprising the step of administering a therapeutically effective amount of a solid form of TH-302 thereof.